GET THE APP

Computed Tomography Features of Follicular Thyroid Adenoma and Ca
Journal of Thyroid Disorders & Therapy

Journal of Thyroid Disorders & Therapy
Open Access

ISSN: 2167-7948

+44 1300 500008

Research Article - (2016) Volume 5, Issue 3

Computed Tomography Features of Follicular Thyroid Adenoma and Carcinoma

Dong Hyun Kim1, Dong Wook Kim1*, Jin Wook Baek1, Yoo Jin Lee1, Young Jun Cho1, Hye Jung Choo1, Sun Joo Lee1, Young Mi Park1, Hye Jin Baek2 and Soo Jin Jung3
1Department of Radiology, Busan Paik Hospital, Inje University College of Medicine, South Korea
2Department of Radiology, Gyeongsang National University School of Medicine and Gyeongsang National University, South Korea
3Department of Pathology, Busan Paik Hospital, Inje University College of Medicine, South Korea
*Corresponding Author: Dong Wook Kim, Department of Radiology, Busan Paik Hospital, Inje University College of Medicine, 75, Bokji-ro, Busanjin-gu, Busan, South Korea, Tel: 82518906549, Fax: 82-51-896-1085 Email: ,

Abstract

Background: No previous study has investigated the computed tomography (CT) characteristics of follicular thyroid adenoma (FTA) and follicular thyroid carcinoma (FTC). This study aimed to compare the CT features of FTA and FTC. Methods: Eighty-seven consecutive patients with FTA or FTC that underwent preoperative neck CT from January 2006 to December 2013 were included. In each case, single radiologist retrospectively examined the corresponding neck CT under blinded conditions for the histopathological results. The CT features of FTA and FTC were evaluated, as well as the specific CT features for differentiating FTC from FTA. Results: After matching the CT and histopathological results, 55 FTAs and 25 FTCs in 80 patients were analyzed. No statistically significant differences were detected in patient age, gender, nodular size, or location between FTA and FTC patients. The most common CT features in both FTA and FTC included low attenuation, intraglandular configuration, smooth margin, round shape, absence of calcifications, and inhomogeneous enhancement. In particular, the prevalence of decreased, iso-, and increased enhancement was similar in both FTA and FTC. The prevalence of homogeneous attenuation in FTC was higher, whereas the prevalence of inhomogeneous attenuation in FTA was higher. The logistic regression analysis revealed no significant differences between FTA and FTC in any CT features, except for the pattern of attenuation (p = 0.002). Conclusion: No specific CT features of FTA and FTC were identified, and CT may be unhelpful for distinguishing FTC from FTA.

<

Keywords: Thyroid nodule, Follicular neoplasm, Follicular adenoma, Follicular carcinoma, Computed tomography

Introduction

Follicular neoplasm of the thyroid gland includes Follicular Thyroid Adenoma (FTA) and Follicular Thyroid Carcinoma (FTC). Further, reports have indicated that FTC is the second most common thyroid cancer after papillary thyroid carcinoma [1].

Thyroid follicular neoplasm can be suspected in 15–30% of fineneedle aspiration for thyroid nodules, whereas cytological diagnoses of suspicious thyroid follicular neoplasm represent a heterogeneous group of lesions including benign follicular hyperplasia, FTA, FTC, Hürthle cell neoplasm, and the follicular variant of papillary thyroid carcinoma [2-4].

However, core needle biopsy is not useful for the management of suspicious follicular neoplasm cytology because it does not provide specific information for FTA or FTC [3,5]. In practice, a surgical approach is used to treat most cases of suspicious follicular neoplasm cytology because a non-surgical biopsy does not aid in distinguishing FTA from FTC [5-7]. Despite the publication of several studies regarding the sonographic differentiation of FTA and FTC, no specific sonographic features of FTA or FTC have been reported [8,9]. Consequently, a diagnostic dilemma still exists for thyroid follicular neoplasm.

The numerous advantages of Computed Tomography (CT), including a wide field of view, objectivity, and detailed display of bone or air-containing organs, has led to the frequent use of CT for evaluating various neck lesions, despite its disadvantages including radiation hazard and the use of iodine-based contrast medium [10].

Although CT is not an established imaging modality for evaluating thyroid nodules, it has been used for tumor-node-metastasis staging in thyroid cancer patients [6,10]. In particular, several studies have attempted to identify characteristic CT features of malignant thyroid nodules [11-14].

However, to the best of our knowledge, no previous studies have investigated the specific CT features for differentiating FTC from FTA using detailed CT features and histopathological results. Therefore, the aim of this study was to assess CT features of FTA and FTC, and to determine specific CT features that would enable the differentiation of FTC from FTA.

Material and Methods

Study population

The Institutional Review Board approved this retrospective study prior to patient selection, and informed consent was waived. From January 2006 to December 2013, 206 patients (176 women and 30 men; mean age, 49.7 ± 12.3 years; age range, 16–79 years) underwent surgical treatment of thyroid follicular neoplasm. Among them, 87 patients (70 women and 17 men; mean age, 49.9 ± 12.6 years; age range, 20–79 years) underwent preoperative neck CT in our hospital. The exclusion criteria included poor quality of CT images (n = 1), no CT delineation of FTC or FTA (n = 2), and unclear match between CT and histopathological findings (n = 4) due to the presence of one or more thyroid nodules which show similar size and location with the follicular neoplasm. Following application of the exclusion criteria, seven patients (six women and one man; mean age, 52.0 ± 10.0 years; age range, 37–69 years) were excluded from the study. Ultimately, 80 patients (64 women and 16 men; mean age, 49.7 ± 12.8 years; age range, 20–79 years) were included.

Neck CT

Neck CT scans were conducted using a 64-channel multi-detector CT scanner (Aquilion One; Toshiba Medical Systems, Otawara, Japan) with injection of contrast medium (iopamidol [Pamiray 370]; 2.5 mL/s, 40–60 seconds delay, and 2 mL/Kg [a total of 100–130 mL]; Dongkook Pharm., Seoul, South Korea) and with a scan range from the floor of the orbit to the sternum. Non-enhanced axial, contrast-enhanced axial, and contrast-enhanced coronal reformatted CT images were acquired in all cases (slice thickness, 3 mm; reconstruction increment, 3 mm; 250 mA, 120 KVp; 140-300 mA).

Image analysis

A single radiologist with 12 years of experience interpreting head and neck CT scans who was blinded to the histopathological results performed the image analysis in all cases using a picture archiving and communication system. Solid thyroid nodule CT features including the degree and pattern of attenuation, configuration, margin, shape, calcification pattern, and the degree and pattern of nodular enhancement were retrospectively evaluated. The adjacent thyroid parenchyma was used as reference to determine the degrees of attenuation and enhancement of thyroid nodules on non-enhanced and contrast enhanced CT images, respectively. The attenuation patterns of thyroid nodules on non-enhanced CT and enhancement patterns of thyroid nodules on contrast enhanced CT were classified as homogeneous or inhomogeneous. The configuration of the thyroid nodule was divided into intraglandular, which was defined as the presence of thyroid parenchyma between the nodule and adjacent thyroid capsule, expansile, which included a blunt angle between the lesion and adjacent thyroid capsule, or exophytic, which included an acute angle between the lesion and adjacent thyroid capsule. The margin of the thyroid nodules was classified as smooth, irregular (spiculated), lobulated, or poorly defined. The nodular shape was classified based on the ratio of anteroposterior to transverse diameters in axial images. First, the anteroposterior and transverse diameters of the nodule were evaluated for parallel orientation with the anteroposterior and transverse axes of the thyroid gland, respectively (Figure 1). Second, the shape of the thyroid nodules was divided into ovoid (anteroposterior diameter/transverse diameter ratio ≤ 0.8), round (0.81). The calcification of the thyroid nodules was classified as none, rim, nodular, punctate (tiny dot-like calcification), complete, or mixed (nodular plus punctate). The degree of nodular enhancement was divided into no/scant, decreased, iso-, and increased, based on a comparison with the adjacent thyroid parenchyma.

thyroid-disorders-therapy-Measurement-anteroposterior

Figure 1A: Measurement of anteroposterior and transverse diameters of the thyroid nodule on CT images. In non-enhanced axial CT images of right thyroid nodule (A) and enhanced axial CT image of left thyroid nodule.

thyroid-disorders-therapy-thyroid-nodule

Figure 1B: Anteroposterior (arrows) and transverse (arrowheads) diameters of each thyroid nodule were parallel with anteroposterior (dotted line) and transverse (solid line) axes of the thyroid gland, respectively.

To avoid investigation bias, nodule selection and image analysis were independently performed in two stages:

• First, the selection, localization, and calibration of a thyroid nodule in all patients were performed based on the CT and histopathological findings of thyroid follicular neoplasm.

• After 2 weeks, image analyses of the target thyroid nodules were performed by a single radiologist blinded to the histopathological results. In the case of multiple FTAs or FTCs, the largest FTA or FTC was selected when two or more FTAs or FTCs were found in the same patient.

Statistical Analysis

The data were tested for normal distribution using the Kolmogorov- Smirnov test. Age at the time of diagnosis and size of the nodule were expressed as the mean ± standard deviation (SD). Mean differences in age and size of the nodules between the two groups (FTA versus FTC) were compared using an independent t-test. Group comparisons of categorical variables were performed using the chi-squared (χ2) test. A univariate logistic regression analysis was used to evaluate the initial predictive power of each variable. The clinical and radiologic variables with a high predictive power (p<0.20, Wald test) were selected and incorporated into a multivariate logistic regression analysis to determine the optimal logistic regression model for differentiating FTC and FTA. A Receiver Operating Characteristic (ROC) curve was constructed to determine the diagnostic performance of each CT finding with the largest Az value used for the differentiation of FTC and FTA. All statistical analyses were performed using statistical analysis software (SPSS, version 17.0, SPSS, Chicago, IL, USA; MedCalc, version 9.0, MedCalc Software, Mariakierke, Belgium), and p values less than 0.05 were considered statistically significant.

Results

Among the 80 patients, the reasons for thyroid surgery included suspicious follicular neoplasm cytology (n = 27), coexisting thyroid malignancy (n = 8), malignant cytology (n = 9), atypia of undetermined significance or follicular lesion of undetermined significance in cytology (n = 7), and patient request despite benign cytology (n = 29).

Based on the histopathological results following thyroid surgery, 55 patients (45 women and 10 men; mean age, 48.7 ± 12.2 years; age range, 20–79 years) had FTA (mean diameter, 28.3 ± 16.0 mm; range, 5.1–85.3 mm), and 25 patients (19 women and 6 men; mean age, 51.8 ± 14.0 years; age range, 22–78 years) had FTC (mean diameter, 34.9 ± 26.3 mm; range, 8.5–105.1 mm). Of the 29 patients with benign cytology, 6 had FTC.

Of the 80 patients, a limited number had multiple FTAs (n = 5) and FTCs (n = 1). The types of thyroid surgery in FTA and FTC patients included total thyroidectomy (n = 20 and 14, respectively), subtotal thyroidectomy (n = 5 and 1, respectively), and hemithyroidectomy (n = 30 and 10, respectively). The locations of FTA and FTC patients were right (n = 33 and 15, respectively), left (n = 22 and 9, respectively), and isthmus (n = 0 and 1, respectively).

There were no statistically significant differences in patient age (p = 0.317), gender (p = 0.546), size (p = 0.173), or location (p = 0.321) of follicular neoplasm between FTA and FTC patients. Of the 25 FTCs, a metastatic regional lymph node was confirmed in only one case.

The results of the analyses of FTA and FTC CT features are presented in Table 1. The most common CT features in both FTA and FTC included low attenuation, intraglandular configuration, smooth margin, round shape, absence of calcifications, and inhomogeneous enhancement (Figures 2 and 3). In particular, the prevalence of decreased, iso-, and increased enhancement was similar in both FTA and FTC. The prevalence of inhomogeneous attenuation was higher in FTA, whereas the prevalence of homogeneous attenuation was higher in FTC. However, no statistically significant differences in FTA and FTC CT features were detected, except for the pattern of attenuation (p = 0.019). Further, the logistic regression analysis revealed no significant differences between the FTA and FTC CT features, except for the pattern of attenuation (p = 0.002; Table 2).

  Follicular thyroid adenoma
(n = 55)
Follicular thyroid carcinoma
(n = 25)
P value
Degree of attenuation     0.497
 Low 54(98.2) 25(100)  
iso- 0(0) 0(0)  
 High 0(0) 0(0)  
 Cystic 1(1.8) 0(0)  
Pattern of attenuation     0.019
 homogeneous 24(43.6) 18(72)  
 inhomogeneous 31(56.4) 7(28)  
Configuration     0.698
intraglandular 34(61.8) 13(52)  
expansile 18(32.7) 10(40)  
exophytic 3(5.5) 2(8)  
Margin     0.073
 Smooth 49(89.1) 19(76)  
irregular (spiculated) 2(3.6) 0(0)  
 lobulated 3(5.5) 6(24)  
 poorly defined 1(1.8) 0(0)  
Shape     0.670
 Ovoid 7(12.7) 5(20)  
 Round 33(60) 13(52)  
 taller-than-wide 15(27.3) 7(28)  
Calcifications     0.814
 None 41(74.5) 17(68)  
 rim (eggshell) 1(1.8) 1(4)  
 Nodular 10(18.2) 5(20)  
 Punctate 2(3.6) 2(8)  
 mixed* 1(1.8) 0(0)  
Degree of enhancement     0.762
 no/scant 2(3.6) 0(0)  
 decreased 22(40) 9(36)  
iso- 15(27.3) 8(32)  
 increased 16(29.1) 8(32)  
Pattern of enhancement     0.612
 homogeneous 9(16.4) 3(12)  
 inhomogeneous 46(83.6) 22(88)  

Table 1: Analysis of computed tomography features of follicular neoplasm in 80 patients. Mixed means punctate plus nodular calcifications. Data are number of items, with percentage in parentheses.

thyroid-disorders-therapy-follicular-thyroid

Figure 2A: A follicular thyroid adenoma (largest diameter, 27.4 mm) in a 46-year-old woman. In non-enhanced A images.

thyroid-disorders-therapy-exophytic-configuration

Figure 2B: Enhanced (B) axial CT images, follicular thyroid adenoma (arrows) in the right lobe shows homogeneous and low attenuation, exophytic configuration, lobulated margin, taller-thanwide shape, absence of calcifications, and inhomogeneous and decreased enhancement.

thyroid-disorders-therapy-year-old-woman

Figure 3A: A follicular thyroid carcinoma (largest diameter, 35.2 mm) in a 41-year-old woman. In non-enhanced.

thyroid-disorders-therapy-expansile-configuration

Figure 3B: Enhanced (B) axial CT images, a follicular thyroid carcinoma (arrows) in the right lobe shows homogeneous and low attenuation, expansile configuration, smooth margin, round shape, absence of calcifications, and inhomogeneous and increased enhancement.

CT features Odds Ratio* P value
Degree of attenuation NA  
Pattern of attenuation 0.10 (0.02, 0.42) 0.002
Configuration 1.85 (0.74, 4.64) 0.190
Margin 2.10 (0.97, 4.56) 0.061
Shape 0.72 (0.31, 4.67) 0.448
Calcifications 1.49 (0.87, 2.53) 0.146
Degree of enhancement 1.00 (0.52, 1.94) 0.995
Pattern of enhancement 4.23 (0.75, 23.88) 0.103

Table 2: Multivariate logistic regression analysis of CT features for differentiating follicular thyroid carcinoma from follicular thyroid adenoma: Numbers in parentheses are 95% confidence intervals. NA = not available (values are not presented for factors that were not included or found to be insignificant in multivariate analysis).

Significant differences in FTA and FTC CT features were further analyzed using a ROC curve analysis, and the sensitivity, specificity, positive predictive value, and negative predictive value of the individual CT features are presented in Table 3. However, no CT features exhibited both high sensitivity and specificity.

CT features Sensitivity (%) Specificity (%) PPV (%) NPV (%) Azvalue* P value
Degree of attenuation 100 1.8 30.8 100 0.509 0.317
Pattern of attenuation 72 56.4 42.9 81.6 0.642 0.013
Configuration 48 61.8 36.4 72.3 0.551 0.409
Margin 24 92.7 60 72.9 0.568 0.167
Shape 20 87.3 4.7 70.6 0.523 0.721
Calcifications 32 74.5 36.4 70.7 0.532 0.577
Degree of enhancement 64 43.6 34 72.7 0.542 0.521
Pattern of enhancement 88 16.4 32.4 75.0 0.522 0.600

Table 3: Diagnostic performance of CT features for differentiating follicular thyroid carcinoma from follicular thyroid adenoma. Az means the largest area under the receiver operating characteristic (ROC) curve. PPV, positive predictive value; NPV, negative predictive value.

Discussion

Thyroid nodules are often detected incidentally following neck CT. Based on previous studies, the malignancy rate of such incidentaloma ranges from 3.9% to 13.3% [11-14]. However, no specific CT features that can reliably distinguish malignant from benign thyroid lesions have been identified [11]. Consequently, it is still unclear whether CT aids the diagnosis of thyroid incidentaloma. Recently, one study demonstrated that the most common CT features for papillary thyroid carcinoma included homogeneous low attenuation, a taller-than-wide shape, absence of calcifications, and homogeneous decreased enhancement [15]. In the present study, the most common CT features of both FTA and FTC included low attenuation, intraglandular configuration, smooth margin, round shape, and absence of calcifications. In particular, the prevalence in the nodular shape and enhancement degree and pattern were different from the previous study for papillary thyroid carcinoma (Figure 2).

To date, no useful imaging or biopsy method for differentiating FTA from FTC has been established [5-7,16]. Thus, many cases of suspicious follicular neoplasm cytology are treated surgically. Although several studies have investigated CT features of malignant thyroid nodules [11-14], no previous studies have attempted to differentiate FTA from FTC (Figure 3).

In the present study, attempts were made to investigate the specific CT features of FTA and FTC in patients who underwent preoperative neck CT and thyroid surgery for FTA or FTC. The prevalence of decreased, iso-, and increased enhancement was similar in both FTA and FTC. In particular, the prevalence of homogeneous attenuation was higher in FTC, whereas inhomogeneous attenuation was higher in FTA. However, no specific CT features reliably distinguished FTA from FTC.

In the present study, a specific CT evaluation of nodular shape was conducted. The basic concept in nodular shape analysis is that the measurement condition on CT should be the same as ultrasonography conditions. On thyroid ultrasonography, anteroposterior and transverse diameters of the nodule are parallel with anteroposterior and transverse axes of the thyroid gland, respectively [17]. In a recent CT study of papillary thyroid carcinoma [15], the assessment of nodular shape revealed a significant difference between ultrasound and CT, but the nodular shape evaluation method in CT was different from the present study. In addition, the present study did not involve the measurement of longitudinal diameter of thyroid nodules.

Our study had several limitations. First, a single radiologist performed the analysis of the CT images and subjectively determined the nodular attenuation and degree of nodular enhancement. Second, there were varying degrees of CT attenuation artifacts from the clavicle, which were not considered. Third, in cases that involved multiple FTAs or FTCs, only one dominant follicular neoplasm for each lobe was selected. Fourth, the possibility of underlying diffuse thyroid disease that, if present, might have affected the analysis of CT features was not considered. Finally, a combination analysis of individual CT features for differentiating FTA from FTC was not performed.

In conclusion, the study results demonstrated that the most common CT features in both FTA and FTC included low attenuation, intraglandular configuration, smooth margin, round shape, absence of calcifications, and inhomogeneous enhancement, and that the prevalence of homogeneous attenuation was higher in FTC, whereas the prevalence of inhomogeneous attenuation was higher in FTA. However, no specific CT features of FTA and FTC were identified. Therefore, CT may be unhelpful for distinguishing FTC from FTA.

References

  1. Palfai TP, Monti PM, Ostafin B, Hutchison K (2000) Effects of nicotine deprivation on alcohol-related information processing and drinking behavior. J Abnorm Psychol 109: 96-105.
  2. Harrison EL, Hinson RE, McKee SA (2009) Experimenting and daily smokers: episodic patterns of alcohol and cigarette use. Addict Behav 34: 484-486.
  3. Howell A, Leyro T, Hogan J, Buckner J, Zvolensky M (2010) Anxiety sensitivity, distress tolerance, and discomfort intolerance in relation to coping and conformity motives for alcohol use and alcohol use problems among young adult drinkers. Addictive Behaviors 35:1144-1147.
  4. Krukowski RA, Solomon LJ, Naud S (2005) Triggers of heavier and lighter cigarette smoking in college students. J Behav Med 28: 335-345.
  5. Reed MB, Wang R, Shillington AM, Clapp JD, Lange JE (2007) The relationship between alcohol use and cigarette smoking in a sample of undergraduate college students. Addictive Behaviors 32: 449-464.
  6. Hughes JR, Kalman D (2006) Do smokers with alcohol problems has more difficulty quitting? Drug Alcohol Depend 82: 91-102.
  7. Hurt RD, Offord KP, Croghan IT, Gomez-Dahl L, Kottke TE, et al. (1996) Mortality following inpatient addictions treatment: Role of tobacco use in a community-based cohort. JAMA: Journal of the American Medical Association 275: 1097-1103.
  8. Lisha NE, Carmody TP2, Humfleet GL2, Delucchi KL2 (2014) Reciprocal effects of alcohol and nicotine in smoking cessation treatment studies.  Addict Behav 39: 637-643.
  9. Taylor B, Rehm J (2006) When risk factors combine: The interaction between alcohol and smoking for aerodigestive cancer, coronary heart disease, and traffic and fire injury. Addictive Behaviors 31: 1522-1535.
  10. Jarvis CM, Hayman LL, Braun LT, Schwertz DW, Ferrans CE, et al. (2007) Cardiovascular risk factors and metabolic syndrome in alcohol- and nicotine-dependent men and women. J CardiovascNurs 22: 429-435.
  11. Joseph AM, Willenbring ML, Nugent SM, Nelson DB (2004) A randomized trial of concurrent versus delayed smoking intervention for patients in alcohol dependence treatment. Journal of Studies on Alcohol, 65: 681-691.
  12. Kodl M, Fu SS, Joseph AM (2006) Tobacco cessation treatment for alcohol-dependent smokers: when is the best time? Alcohol Res Health 29: 203-207.
  13. Fu S, Kodl M, Willenbring M, Nelson D, Nugent S, et al. (2008) Ethnic differences in alcohol treatment outcomes and the effect of concurrent smoking cessation treatment. Drug and Alcohol Dependence 92: 61-68.
  14. Holt LJ, Litt MD, Cooney NL (2012) Prospective analysis of early lapse to drinking and smoking among individuals in concurrent alcohol and tobacco treatment. Psychology of Addictive Behaviors 26:561-572.
  15. Centers for Disease Control and Prevention (CDC) (2009) Cigarette smoking among adults and trends in smoking cessation - United States, 2008. MMWR Morb Mortal Wkly Rep 58: 1227-1232.
  16. Irving LM, Seidner AL, Burling TA, Thomas RG, Brenner GF (1994) Drug and alcohol abuse inpatients' attitudes about smoking cessation. J Subst Abuse 6: 267-278.
  17. Macnee CL, Talsma A (1995) Development and testing of the barriers to cessation scale. Nurs Res 44: 214-219.
  18. Orleans CT, Rimer BK, Cristinzio S, Keintz MK, Fleisher L (1991) A national survey of older smokers: treatment needs of a growing population. Health Psychol 10: 343-351.
  19. Kristeller JL (1994) Treatment of hard-core, high-risk smokers using FDA approved pharmaceutical agents: An oral health team perspective. Health Values 18: 25-32.
  20. Asher MK, Martin RA, Rohsenow DJ, MacKinnon S, Traficante R, et al. (2003) Perceived barriers to quitting smoking among alcohol dependent patients in treatment. Journal of Substance Abuse Treatment 24: 169-174.
  21. Martin RA, Rohsenow DJ, MacKinnon SV, Abrams DB, Monti PM (2006) Correlates of motivation to quit smoking among alcohol dependent patients in residential treatment. Drug Alcohol Depend 83: 73-78.
  22. Marlatt GA, Gordon JR (1985) Relapse prevention. New York: Guilford Press.
  23. Velicer WF, DiClemente CC, Prochaska JO, Brandenburg N (1985) Decisional balance measure for assessing and predicting smoking status. J PersSoc Psychol 48: 1279-1289.
  24. DiClemente CC, Prochaska JO (1982) Self-change and therapy change of smoking behavior: a comparison of processes of change in cessation and maintenance. Addict Behav 7: 133-142.
  25. Curry SJ, Grothaus L, McBride C (1997) Reasons for quitting: intrinsic and extrinsic motivation for smoking cessation in a population-based sample of smokers. Addict Behav 22: 727-739.
  26. Baha M, Le Faou AL (2010) Smokers' reasons for quitting in an anti-smoking social context. Public Health 124: 225-231.
  27. Curry SJ, McBride C, Grothaus LC, Louie D, Wagner EH (1995) A randomized trial of self-help materials, personalized feedback, and telephone counseling with nonvolunteer smokers. J Consult Clin Psychol 63: 1005-1014.
  28. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M (1993) Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction 88: 791-804.
  29. First MB, Williams JB, Spitzer RL, Gibbon M (2002) Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Clinical Trials Version (SCID-CT). New York: Biometrics Research, New York State Psychiatric Institute.
  30. Brown RA, Lejuez CW, Kahler CW, Strong DR (2002) Distress tolerance and duration of past smoking cessation attempts. J Abnorm Psychol 111: 180-185.
  31. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO (1991) The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 86: 1119-1127.
  32. Pomerleau CS, Carton SM, Lutzke ML, Flessland KA, Pomerleau OF (1994) Reliability of the Fagerstrom Tolerance Questionnaire and the Fagerstrom Test for Nicotine Dependence. Addict Behav 19: 33-39.
  33. Fagerstrom KO, Heatherton TF, Kozlowski LT (1990) Nicotine addiction and its assessment. Ear Nose Throat J 69: 763-765.
  34. Filbey FM, Claus E, Audette AR, Niculescu M, Banich MT, et al. (2007) Exposure to the taste of alcohol elicits activation of the mesocorticolimbicneurocircuitry. Neuropsychopharmacology 33: 1391-1401.
  35. Fleming MF, Barry KL, MacDonald R (1991) The alcohol use disorders identification test (AUDIT) in a college sample. Int J Addict 26: 1173-1185.
  36. Cherpitel CJ (1995) Analysis of cut points for screening instruments for alcohol problems in the emergency room. J Stud Alcohol 56: 695-700.
  37. Macnee CL, Talsma A (1995) Predictors of progress in smoking cessation. Public Health Nurs 12: 242-248.
  38. Curry S, Wagner EH, Grothaus LC (1990) Intrinsic and extrinsic motivation for smoking cessation. J Consult Clin Psychol 58: 310-316.
  39. McBride CM, Pollak KI, Bepler G, Lyna P, Lipkus IM, et al. (2001) Reasons for quitting smoking among low-income African American smokers. Health Psychol 20: 334-340.
  40. Bonn-Miller MO, Zvolensky MJ (2009) An evaluation of the nature of marijuana use and its motives among young adult active users. Am J Addict 18: 409-416.
  41. Buckner JD, Zvolensky MJ, Schmidt NB (2012) Cannabis-related impairment and social anxiety: the roles of gender and cannabis use motives. Addict Behav 37: 1294-1297.
  42. Agrawal A, Budney AJ, Lynskey MT (2012) The co-occurring use and misuse of cannabis and tobacco: a review. Addiction 107: 1221-1233.
  43. Degenhardt L, Hall W, Lynskey M (2001) The relationship between cannabis use and other substance use in the general population. Drug Alcohol Depend 64: 319-327.
  44. Cohen J, Cohen P (1983) Applied multiple regression/correlation analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum.
  45. Cohen J, Cohen P, West SG, Aiken LS (2003) Applied multiple regression/correlation analysis for the behavioral sciences (3rd ed.). Mahwah, NJ US: Lawrence Erlbaum Associates Publishers.
  46. Lipkus IM, Feaganes JR, Green JD, Sedikides C (2001) The Relationship Between Attitudinal Ambivalence and Desire to Quit Smoking Among College Smokers. Journal of Applied Social Psychology, 31: 113-133.
  47. Wilson SJ, Creswell KG, Sayette MA, Fiez JA (2013) Ambivalence about smoking and cue-elicited neural activity in quitting-motivated smokers faced with an opportunity to smoke.  Addict Behav 38: 1541-1549.
  48. Festinger LA (1957) A theory of cognitive dissonance. Evanston, IL: Row, Peterson.
  49. Markowitz LJ (2000) Smoker's perceived self-exemption from health risks. Psi Chi Journal of Undergraduate Research 5: 119-124.
  50. Jamieson P, Romer D (2001)What do young people think they know about the risks of smoking? In P. Slovic (Ed.), Smoking: Risk, perception, and policy (pp. 51-63). Thousand Oaks, CA US: Sage Publications, Inc.
  51. Schane RE, Glantz SA, Ling PM (2009) Social smoking implications for public health, clinical practice, and intervention research. American Journal of Preventive Medicine 37: 124-131.
  52. DaniJA, De Biasi M (2001) Cellular mechanisms of nicotine addiction. PharmacolBiochemBehav 70: 439-446.
  53. Nestler EJ (2005) Is there a common molecular pathway for addiction? Nat Neurosci 8: 1445-1449.
  54. Ehrman RN, Robbins SJ, Bromwell MA, Lankford ME, Monterosso JR, et al. (2002) Comparing attentional bias to smoking cues in current smokers, former smokers, and non-smokers using a dot-probe task. Drug Alcohol Depend 67: 185-191.
  55. Kerst WF, Waters AJ (2014)Attentional retraining administered in the field reduces smokers’ attentional bias and craving.
  56. Wiers RW, Rinck M, Kordts R, Houben K, Strack F (2010) Retraining automatic action-tendencies to approach alcohol in hazardous drinkers. Addiction 105: 279-287.
  57. Raupach T, West R, Brown J (2013) The most "successful" method for failing to quit smoking is unassisted cessation. Nicotine Tob Res 15: 748-749.
  58. Korte KJ, Capron DW, Zvolensky M, Schmidt NB (2013) The Fagerström test for nicotine dependence: do revisions in the item scoring enhance the psychometric properties? Addict Behav 38: 1757-1763.
Citation: Kim DH, Kim DW, Baek JW, Lee YJ, Cho YJ, et al. (2016) Computed Tomography Features of Follicular Thyroid Adenoma and Carcinoma. Thyroid Disorders Ther 5:205.

Copyright: © 2016 Kim DH, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Top